In these xenografts, we found that more than 50% of the vessels in DLL4-overexpressing xenografts showed a strong FABP4 expression compared with 10–20% of the vessels in the control (empty vector, EV) tumours (P<0.00001) (Figures 1a and b). This evidence concerns the gene DLL4 and neoplasm.